Market Overview

Sanofi Buys OTC Antacid Rolaids from J&J's McNeil-PPC

Share:
Related SNY
vTv Therapeutics Shares Initiated With Buy Rating, $13 Target
Benzinga's Top Initiations
Regeneron-Sanofi Could Beat Pfizer, Roche, AstraZeneca On Eczema (Investor's Business Daily)
Related JNJ
vTv Therapeutics Shares Initiated With Buy Rating, $13 Target
First Trust Gets Smart With New Sector ETFs
The Vetr community has upgraded $JNJ to 3.5-Stars. (Vetr)

Sanofi (NYSE : SNY) today announced that its US Consumer Healthcare Division, Chattem, Inc., completed the acquisition of the worldwide rights to the Rolaids^® brand from McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.

Posted-In: News M&A

 

Related Articles (JNJ + SNY)

View Comments and Join the Discussion!